Heart Bypass Surgery

The silkworm holds a treasure beyond the luxury of exquisite textiles. It's called serrapeptase (AKA Serratio Peptidase or SP, DanzenTM, AniflazymTM SerraZymeTM), a powerful protolytic enzyme that dissolves all nonliving tissue, including blood clots, cysts, arterial plaque and inflammation in all forms. The mighty enzyme offers a viable alternative to salicylates (such as aspirin), ibuprofen, and NSAIDS as well as steroidsa boon for those suffering with rheumatoid arthritis and a wide array of other autoimmune diseases that affect the inflammatory response, including ulcerative colitis, psoriasis, uveitis, allergies, and some forms of cancer. While steroidal and nonsteroidal antiinflammatory drugs may offer temporary, symptomatic relief from pain, swelling and inflammation, they may also be immunosuppressive and known to hold dangerous side effects. Serrapeptase, on the other hand, eases pain and swelling with no inhibitory effects on prostaglandins and no gastrointestinal side effects. The immunologically active enzyme is completely bound to the alpha 2 macroglobulin in biological fluids. The physiologic agent is isolated from the microorganism Serratia E15, an enzyme naturally present in the silkworm intestine which allows the emerging moth to dissolve its cocoon. Clinical use of serrazyme as an antiinflammatory in Europe and Asia spans over twenty five years. Treatment includes chronic sinusitis, elimination of bronchopulmonary secretions (the enzyme breaks down protein fibers, allowing mucous to thin), sprains and torn ligaments, and other traumatic injuries, idiopathic edema, as well as postoperative inflammation. Studying postoperative swelling and pain reduction of the upper ankle joint, a test was carried out in 3 randomized groups of 66 patients, each with fresh rupture of the lateral ligament treated surgically between December 1986 and April 1987. The group receiving SP saw a 50% decrease in swelling on the third postoperative day. Decreased pain, for the most part, correlated with reduction in swelling. The SP group became rapidly pain-free. The two control groups, using traditional elevation of the leg, bed rest, with and without applications of ice, had no reduction in swelling at that time. (Esch PM, Gerngross H, Fabian A, Fortachr Med,107(4):67.8, 71-2 1989 Feb 10) Another multi-centre, double-blind, placebo-controlled trial was carried out to investigate the clinical efficacy of SP in 174 patients who underwent Caldwell-Luc antrotomy for chronic empyema. Eighty-eight patients received 10 mg SP 3 times the day before surgery, once the night of the operation and 3 times daily for 5 days after surgery; the other 86 received a placebo. The degree of swelling in the serrapeptase-treated patients was significantly less than that in the placebo-treated patients at every point of observation after surgery up to the 5th day. Maximal buccal swelling throughout all the postoperative points of observation was also significantly smaller in size in the SP group. No side effects were reported. (Tachibana M, Mizukosi 0, Harada Y, Kawamoto K, Nakai Y. Source: Pharmathera-peutica, 3(8):526-30 1984). Additionally, SP in a 70 patient, double-blind controlled trial treating breast engorgement saw SP improve breast pain and swelling in significant numbers of the treatment group with no adverse reactions. (Kee WH, Tan SL; Lee V, Salmon YM .Singapore Med J, 30 (I) :48-54 1989 Feb) Researchers in Germany have used SP to treat atherosclerosis since serrapeptase helps to digest atherosclerotic plaque without harming healthy cells lining the arterial wall. The hardened, narrow arterial wall is considered the cumulative result of microscopic trauma with inflammation occurring in the presence of oxidized lipids serrapeptase works on both inflammation as well as dissolving the avital plaque. Unlike cholesterol-blocking drugs, serapeptase clears the avital tissue from the arterial wall without interfering with cholesterol synthesis. In fact, when taking serrapeptase, cholesterol levels may rise as it is dissolved from the arteries to be eliminated from the body (cholesterol in its pure state is an antioxidant and a necessary component of steroidal hormones and the major organ systems in the body). Medications blocking cholesterol biosynthesis hold the threat of liver, eye, lung and other soft tissue damage. While studies with SP in the treatment of coronary artery disease are relatively new; some literature reports SP as being superior to, and faster than, chelation. The late German physician Dr. Hans Nieper used serrapeptase to treat arterial blockage in his coronary patients, reporting that serrapeptase also dissolves blood clots, and causes varicose veins to shrink or diminish. Dr. Nieper told of a woman scheduled for hand amputation and a man scheduled for bypass surgery; both recovered quickly without surgery after treatment with serrapeptase. In addition, widespread use has included fibrocystic breast disease and carpal tunnel syndrome. The enzyme is also used to facilitate the therapeutic effect of antibiotics in the treatment of infection. In urology serrapeptase has been successfully employed to treat cystitis and epididymitis. Serrapeptase is available as SerraZyme in 10 mg enterically coated tablets that are equivalent to 20,000 IU activity. Recommended Usage: For inflammation is 1 tablets three times daily on an empty stomach. For arterial blockage 1 tablets twice daily or as directed by your health professional. (In acute conditions, your health care professional may recommend that you take 2 tablets on an empty stomach 6 times per day). Copyright, Julia Busch 2000